Sponsors (5)
The bill raises the safety of imported shrimp by allowing the FDA to block imports from countries without equivalent inspection systems, but that safety gain may come with higher consumer prices, increased compliance costs, and potential supply-chain disruptions.
U.S. consumers and seafood buyers face a lower risk of contaminated or unsafe imported shrimp because the FDA can block shrimp from countries without equivalent inspection systems starting one year after enactment, and foreign producers are incentivized to upgrade inspection and legal frameworks to meet equivalence requirements.
U.S. consumers and seafood retailers could face higher shrimp prices or reduced availability if imports from noncompliant countries are barred starting one year after enactment.
U.S. importers and foreign exporters will incur compliance costs to produce equivalence documentation and meet inspection requirements, raising business costs that may be passed on to consumers.
Workers and businesses in seafood supply chains (transportation, processing, distribution) could experience trade disruptions and job impacts if exporting countries cannot meet the criteria and shipments are blocked.
Based on analysis of 2 sections of legislative text.
Requires FDA to secure agreements and find foreign shrimp-inspection systems equivalent, and to refuse shrimp imports from countries that don't meet those standards starting one year after enactment.
Introduced May 13, 2025 by Mike Ezell · Last progress May 13, 2025
Requires the Food and Drug Administration to secure formal arrangements with foreign governments that host registered facilities producing shrimp for the U.S., and to bar shrimp imports from countries that do not enter such agreements or whose food-inspection systems fail to meet specified equivalence criteria. Enforcement of the import ban begins one year after the law is enacted, and the Department of Health and Human Services must report to Congress within one year and then annually on implementation.